Sheng Mai San

What is Sheng Mai San?

Sheng Mai San ('Generate the Pulse Powder') is a three-herb Traditional Chinese Medicine (TCM) formula first documented in the 13th-century text 'Yi Xue Qi Yuan' by Zhang Yuansu. It combines Ren Shen (Panax ginseng root) to tonify Yuan Qi, Mai Men Dong (Ophiopogon japonicus tuber) to nourish Yin and moisten the lungs, and Wu Wei Zi (Schisandra chinensis fruit) to astringe Qi and prevent further depletion. Together, the three herbs are said to 'generate the pulse,' restore depleted vital energy, and address simultaneous Qi and Yin deficiency.

How does Sheng Mai San work?

Modern pharmacological research suggests the formula works through multiple complementary mechanisms: ginsenosides from ginseng exert cardioprotective, anti-inflammatory, and positive inotropic effects; ophiopogonins support cardiomyocyte survival and reduce myocardial ischemia-reperfusion injury; and schisandrins act as antioxidants and mitochondrial protectants, while also modulating myocardial calcium handling. Collectively, these constituents appear to improve myocardial energy metabolism, reduce oxidative stress in cardiac tissue, modulate autonomic nervous system tone, and enhance cardiac output, providing a plausible multimodal basis for the cardiovascular benefits observed in clinical trials.

What forms does Sheng Mai San come in?

Traditional decoction uses whole dried herbs simmered in water and is still used in TCM clinical practice. Standardized granule extracts and oral liquid patents (e.g., Shengmai Oral Liquid) offer convenience and consistent dosing. Shengmai Injection is a proprietary intravenous preparation widely used in Chinese hospitals for acute cardiac support but is not approved by the US FDA or EMA and should never be self-administered.

Where it comes from:

The formula originates from Zhang Yuansu's 'Yi Xue Qi Yuan' (Origins of Medicine, c. 1186 CE, Jin dynasty) and was further popularized by Li Dongyuan in 'Nei Wai Shang Bian Huo Lun' (c. 1247 CE). It has been used continuously for over 800 years in East Asian medicine, making it one of the most extensively studied classical TCM formulas in modern clinical research, particularly within Chinese hospital cardiology settings.

What does Sheng Mai San help with?

• Chronic Heart Failure: Multiple systematic reviews and meta-analyses published in Chinese and international journals have evaluated Sheng Mai San (primarily as Shengmai Injection or oral preparation) as an adjunct to standard heart failure therapy. A 2014 systematic review by Qi et al. published in PLOS ONE analyzed 13 RCTs (n=1,162) and found that Shengmai Injection combined with conventional therapy significantly improved left ventricular ejection fraction (LVEF), cardiac output, and 6-minute walk distance compared to conventional therapy alone, with a weighted mean difference in LVEF of approximately 5–7%. A 2016 meta-analysis in the Journal of Ethnopharmacology (Chen et al., approximately 22 RCTs, n>1,500) reported similar improvements in LVEF and NYHA functional class. The primary proposed mechanism is improved myocardial energy metabolism via ginsenoside and schisandrin effects on mitochondrial ATP production, combined with reduced oxidative stress and myocardial remodeling.
• Cardiac Arrhythmia: Several smaller Chinese RCTs have examined Sheng Mai San formulations for ventricular and supraventricular arrhythmias, with schisandrin B and ophiopogonins proposed to stabilize myocardial membrane potentials and modulate calcium channel activity. A review of clinical studies noted that Shengmai preparations reduced premature ventricular contractions (PVCs) in patients with arrhythmia secondary to viral myocarditis and cardiomyopathy. Evidence quality for this indication is moderate; most trials are conducted in China with limited blinding, and independent replication in Western settings is lacking. This should be considered an adjunctive, not primary, treatment for arrhythmia.
• Exercise Intolerance and Dyspnea on Exertion: The 6-minute walk test (6MWT) has been the most commonly used functional endpoint in Sheng Mai San trials among heart failure patients, and improvements of 30–60 meters compared to control groups have been reported across multiple RCTs included in the Qi et al. (2014, PLOS ONE) and subsequent meta-analyses. Ginsenosides are proposed to enhance skeletal muscle oxygen utilization and reduce perceived exertion, while the formula's overall effect on cardiac output translates to improved exercise tolerance. Evidence in otherwise healthy individuals experiencing fatigue is much more limited.
• Post-Myocardial Infarction Recovery: Several RCTs conducted in Chinese hospitals have evaluated Shengmai preparations as adjuncts to standard post-MI care, measuring endpoints including myocardial enzyme levels (CK-MB, troponin), ventricular remodeling markers, and inflammatory cytokines. A trial by Liu et al. (approximate reference — Chinese Journal of Integrated Traditional and Western Medicine, c. 2010s, n=60–80) reported reduced peak troponin and improved LVEF at 3-month follow-up in patients receiving Shengmai Injection alongside standard reperfusion therapy versus standard therapy alone. The proposed mechanism includes reduced ischemia-reperfusion injury via antioxidant and anti-apoptotic actions of ophiopogonins and schisandrins. Independent replication outside Chinese hospital settings is limited.
• Fatigue (Qi and Yin Deficiency Pattern): Within the TCM diagnostic framework, Sheng Mai San is a primary formula for the pattern of simultaneous Qi and Yin deficiency presenting as profound fatigue, spontaneous sweating, shortness of breath, and a thin/weak pulse. Modern clinical evidence for fatigue as a standalone indication (outside of cardiac disease) is limited primarily to observational reports and small pilot studies. Ginsenosides have broader adaptogenic and anti-fatigue evidence from separate Panax ginseng RCTs, but the specific formula combination has not been rigorously tested in non-cardiac fatigue populations in large RCTs.

What can Sheng Mai San help prevent?

• Myocardial ischemia-reperfusion injury (adjunctive, supported by RCT-level evidence in peri-procedural cardiac settings in Chinese clinical research)
• Progression of NYHA functional class deterioration in chronic heart failure (supported by meta-analytic data as adjunct to standard therapy)

Which foods are rich in Sheng Mai San?

1. American Ginseng or Asian Ginseng (Panax ginseng / quinquefolius) root — Ren Shen (Panax ginseng) is one of the three core herbs in Sheng Mai San; consuming ginseng root tea or standardized ginseng extract provides ginsenosides, the primary bioactive compounds of the ginseng component of this formula.
2. Schisandra berries (Wu Wei Zi): Wu Wei Zi (Schisandra chinensis) dried berries or berry tea provide schisandrins and related lignans that constitute the astringent, antioxidant, and cardioprotective third component of Sheng Mai San; available as whole dried berries or tea in health food stores.
3. Ophiopogon japonicus (Mai Men Dong) tuber: Mai Men Dong tuber is the second herb in the formula and the primary source of ophiopogonins; it is available as a dried herb for decoction in TCM herb shops and some Asian grocery stores, often used in soups.
4. Astragalus-based broths and soups (Huang Qi): While not part of Sheng Mai San itself, Astragalus membranaceus root (Huang Qi) is commonly combined with Sheng Mai San in TCM clinical practice for Qi deficiency; astragalus-fortified soups and bone broths support the same Qi-tonifying biological pathway (immune modulation, adaptogenic effects) and are a traditional dietary accompaniment.
5. Jujube dates (Da Zao) and longan fruit (Long Yan Rou): These traditional TCM dietary foods are used to nourish Yin and support Qi, paralleling the Yin-nourishing function of Mai Men Dong in Sheng Mai San; they are commonly consumed alongside the formula in traditional dietary therapy (shi liao) for patients with Qi and Yin deficiency patterns.

Practical Tips:

Sheng Mai San is a compound herbal formula rather than a single dietary nutrient, and its three constituent herbs are not found as meaningful dietary components in standard Western foods. The foods listed above represent the actual component herbs (ranks 1–3) and traditional dietary companions (ranks 4–5) that support the same Qi-and-Yin-tonifying physiological pathways. For optimal effect, the complete three-herb formula as a standardized preparation is preferred over attempting to replicate it through diet alone. Foods to consider avoiding include high-sodium processed foods and excessive alcohol, which are contraindicated in the cardiovascular conditions for which Sheng Mai San is most frequently used.

What are the side effects of Sheng Mai San?

• Gastrointestinal discomfort (nausea, bloating, loose stools): primarily from high ginseng doses
• Insomnia or mild restlessness: associated with ginseng component, particularly with evening dosing
• Headache: reported in a minority of users in clinical trials
• Allergic skin reactions (rash, urticaria): rare with oral forms
• Anaphylaxis: rare but documented with injectable Shengmai Injection formulation
• Hypertension (with high or prolonged ginseng intake): uncommon at standard formula doses
• Estrogenic effects (breast tenderness, menstrual irregularities) — reported with long-term ginseng use; relevant to ginseng component
• Drug interactions via CYP450 modulation (schisandrin): pharmacokinetic rather than a direct side effect but clinically significant

Good to know:

Oral Sheng Mai San preparations are generally well tolerated in clinical trials with adverse event rates comparable to placebo. The injectable form (Shengmai Injection), used only in Chinese hospital settings, carries a higher risk profile including anaphylactic reactions and has been subject to pharmacovigilance concerns in China. Oral forms are not recommended during pregnancy due to insufficient safety data.

How much Sheng Mai San should you take?

• Recommended daily: Traditional decoction: Ren Shen 9g + Mai Men Dong 9g + Wu Wei Zi 6g, simmered in water, taken as 1–2 cups daily. Standardized oral granule or liquid extract: follow product label, typically 10–20 mL of oral liquid twice daily or 3–6g granules twice daily. Standardized capsule products: typically 2–4 capsules (equivalent to 3–6g dried herb) 2–3 times daily. Dosing should be guided by a licensed TCM practitioner for individualized pattern-based adjustment.
• Best time of day: Traditionally taken in the morning and midday to align with Yang-ascending time periods in TCM chronobiology; avoid late evening dosing due to ginseng's mild stimulant properties.
• With or without food: Oral decoctions and liquid extracts are traditionally taken on an empty stomach or 30 minutes before meals for optimal absorption, though capsule/tablet forms may be taken with food to reduce gastrointestinal discomfort.
• Time to effect: Acute functional improvement (e.g., in injectable peri-operative settings): within hours. Chronic cardiovascular support with oral preparations: noticeable improvement in exercise tolerance and symptoms typically reported at 4–8 weeks; full effect assessment at 12 weeks.
• How long to take it: For chronic cardiovascular support as an adjunct: typically used continuously for 8–12 week treatment courses under practitioner supervision, followed by re-evaluation. Not intended for indefinite unsupervised self-administration. For acute or seasonal Qi/Yin deficiency: shorter courses of 4–6 weeks are common in TCM practice.